OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic—An EAACI position paper
Ludger Klimek, Marek Jutel, Jean Bousquet, et al.
Allergy (2020) Vol. 76, Iss. 3, pp. 677-688
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, et al.
International Forum of Allergy & Rhinology (2023) Vol. 13, Iss. 4, pp. 293-859
Open Access | Times Cited: 225

Advances and highlights in biomarkers of allergic diseases
İsmail Öğülür, Yağız Pat, Özge Ardıçlı, et al.
Allergy (2021) Vol. 76, Iss. 12, pp. 3659-3686
Open Access | Times Cited: 150

COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Oliver Pfaar, Ludger Klimek, Marek Jutel, et al.
Allergy (2020) Vol. 76, Iss. 3, pp. 648-676
Open Access | Times Cited: 108

Asthma and COVID-19: a systematic review
Natália Ferreira Mendes, Carlos Poblete Jara, Eli Mansour, et al.
Allergy Asthma and Clinical Immunology (2021) Vol. 17, Iss. 1
Open Access | Times Cited: 59

Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
Caroline Huart, Carl Philpott, Aytuğ Altundağ, et al.
International Forum of Allergy & Rhinology (2021) Vol. 11, Iss. 7, pp. 1041-1046
Open Access | Times Cited: 55

Highlights in the advances of chronic rhinosinusitis
Xinni Xu, Sietze Reitsma, De Yun Wang, et al.
Allergy (2021) Vol. 76, Iss. 11, pp. 3349-3358
Closed Access | Times Cited: 44

Olfactory and gustatory disorders in COVID-19
Ludger Klimek, Jan Hagemann, Julia Döge, et al.
Allergo Journal International (2022) Vol. 31, Iss. 7, pp. 243-250
Open Access | Times Cited: 31

The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19
Yadong Gao, Ioana Agache, Mübeccel Akdiş, et al.
International Immunology (2021) Vol. 34, Iss. 4, pp. 177-188
Open Access | Times Cited: 39

Chronic Rhinosinusitis and COVID-19
Concepció Marı́n, Thomas Hummel, Zheng Liu, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1423-1432
Open Access | Times Cited: 27

Pathogenesis of chronic rhinosinusitis with nasal polyp and a prominent T2 endotype
Said Ahmad Shah, Masayoshi Kobayashi
Heliyon (2023) Vol. 9, Iss. 9, pp. e19249-e19249
Open Access | Times Cited: 13

Distinct expression of SARS‐CoV‐2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps
Ming Wang, Xiangting Bu, Gao‐Li Fang, et al.
Allergy (2020) Vol. 76, Iss. 3, pp. 789-803
Open Access | Times Cited: 34

Interplay Between COVID- 19 and Chronic Rhinosinusitis: Clinical Insights
Yuxin Zhou, Li Pan, Xianghong Wang, et al.
Current Treatment Options in Allergy (2025) Vol. 12, Iss. 1
Closed Access

Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: A survey by the EAACI Asthma Section
Ibón Eguíluz-Gracia, Maarten van den Berge, Cristina Boccabella, et al.
Allergy (2021) Vol. 76, Iss. 9, pp. 2776-2784
Open Access | Times Cited: 23

SARS-CoV-2 Infection, A Risk Factor for Pituitary Apoplexy? A Case Series and Literature Review
Christina Hazzi, Noémie Villemure‐Poliquin, Sylvie Nadeau, et al.
Ear Nose & Throat Journal (2023) Vol. 103, Iss. 1_suppl, pp. 153S-161S
Open Access | Times Cited: 8

Novel therapeutic approaches targeting endotypes of severe airway disease
Maria De Filippo, Martina Votto, Amelia Licari, et al.
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 10, pp. 1303-1316
Closed Access | Times Cited: 17

The Frequency and Clinical Assessment of COVID-19 in Patients With Chronic Rhinosinusitis
Allahkarm Akhlaghi, Amirhossein Darabi, Marzieh Mahmoodi, et al.
Ear Nose & Throat Journal (2021) Vol. 103, Iss. 2, pp. NP98-NP103
Open Access | Times Cited: 14

Impact of the COVID-19 on asthma control among children: A systematic review
Mai Hamadneh, Alaa Alquran, Rami Manna
Deleted Journal (2023) Vol. 12, Iss. 3
Open Access | Times Cited: 5

A Decade of Pathogenesis Advances in Non-Type 2 Inflammatory Endotypes in Chronic Rhinosinusitis: 2012–2022
Na Cui, Xuewei Zhu, Chen Zhao, et al.
International Archives of Allergy and Immunology (2023) Vol. 184, Iss. 12, pp. 1237-1253
Open Access | Times Cited: 5

Corticosteroid Use in Otolaryngology: Current Considerations During the COVID‐19 Era
C. W. David Chang, Edward D. McCoul, Selena E. Briggs, et al.
Otolaryngology (2021) Vol. 167, Iss. 5, pp. 803-820
Closed Access | Times Cited: 12

Four years into the COVID‐19 pandemic: Timely published articles for patient care and EAACI's leadership role
Marı́a José Torres, Ludger Klimek, Ioana Agache, et al.
Allergy (2024) Vol. 79, Iss. 8, pp. 2031-2033
Open Access | Times Cited: 1

Incidence of coronavirus disease (COVID-19) in patients with different degrees of chronic rhinosinusitis with nasal polyps
E. V. Lyubimova, Е. Л. Савлевич, А. В. Зурочка, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 9, pp. 168-176
Open Access | Times Cited: 1

Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems
Ruslan R. Safarov, О. В. Федотова, Anastasia Uvarova, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1180-1180
Open Access | Times Cited: 1

Asthma and COVID-19 - A systematic review
Natália Ferreira Mendes, Carlos Poblete Jara, Eli Mansour, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 11

An integrative review on the uses of plant-derived bioactives formulated in conventional and innovative dosage forms for the local treatment of damaged nasal cavity
Eleonora Casula, Maria Letizia Manca, Maria Manconi
International Journal of Pharmaceutics (2021) Vol. 610, pp. 121229-121229
Closed Access | Times Cited: 10

Page 1 - Next Page

Scroll to top